Abucayon E, Sweeney S, Matyas G
ACS Omega. 2024; 9(17):19637-19644.
PMID: 38708252
PMC: 11064170.
DOI: 10.1021/acsomega.4c01524.
Rikhi N, Sei C, Rao M, Schuman R, Kroscher K, Matyas G
Vaccines (Basel). 2023; 11(9).
PMID: 37766144
PMC: 10537791.
DOI: 10.3390/vaccines11091468.
Abucayon E, Rao M, Matyas G, Alving C
Pharmaceutics. 2023; 15(9).
PMID: 37765181
PMC: 10537867.
DOI: 10.3390/pharmaceutics15092212.
Casas-Sanchez A, Ramaswamy R, Perally S, Haines L, Rose C, Aguilera-Flores M
PLoS Pathog. 2023; 19(3):e1011269.
PMID: 36996244
PMC: 10089363.
DOI: 10.1371/journal.ppat.1011269.
Jobe O, Kim J, Pinto D, Villar Z, Hewitt T, Duncan E
Sci Rep. 2022; 12(1):7570.
PMID: 35534646
PMC: 9082986.
DOI: 10.1038/s41598-022-11230-8.
Liposomes for malaria management: the evolution from 1980 to 2020.
Memvanga P, Nkanga C
Malar J. 2021; 20(1):327.
PMID: 34315484
PMC: 8313885.
DOI: 10.1186/s12936-021-03858-0.
Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice.
Komla E, Torres O, Jalah R, Sulima A, Beck Z, Alving C
Vaccines (Basel). 2021; 9(6).
PMID: 34205869
PMC: 8229309.
DOI: 10.3390/vaccines9060573.
Liposome Formulations as Adjuvants for Vaccines.
Rao M, Peachman K, Alving C
Curr Top Microbiol Immunol. 2020; 433:1-28.
PMID: 33165871
DOI: 10.1007/82_2020_227.
Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl Analogues.
Barrientos R, Bow E, Whalen C, Torres O, Sulima A, Beck Z
Mol Pharm. 2020; 17(9):3447-3460.
PMID: 32787282
PMC: 7482402.
DOI: 10.1021/acs.molpharmaceut.0c00497.
Army Liposome Formulation (ALF) family of vaccine adjuvants.
Alving C, Peachman K, Matyas G, Rao M, Beck Z
Expert Rev Vaccines. 2020; 19(3):279-292.
PMID: 32228108
PMC: 7412170.
DOI: 10.1080/14760584.2020.1745636.
Enhanced Immunogenicity and Protective Efficacy of a Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21.
Ramakrishnan A, Schumack N, Gariepy C, Eggleston H, Nunez G, Espinoza N
mSphere. 2019; 4(3).
PMID: 31043512
PMC: 6495334.
DOI: 10.1128/mSphere.00101-19.
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease.
Portillo S, Zepeda B, Iniguez E, Olivas J, Karimi N, Moreira O
NPJ Vaccines. 2019; 4:13.
PMID: 30911415
PMC: 6430786.
DOI: 10.1038/s41541-019-0107-7.
Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
Beck Z, Torres O, Matyas G, Lanar D, Alving C
J Control Release. 2018; 275:12-19.
PMID: 29432824
PMC: 5878139.
DOI: 10.1016/j.jconrel.2018.02.006.
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.
Sulima A, Jalah R, Antoline J, Torres O, Imler G, Deschamps J
J Med Chem. 2017; 61(1):329-343.
PMID: 29236495
PMC: 5767880.
DOI: 10.1021/acs.jmedchem.7b01427.
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
Wieczorek L, Krebs S, Kalyanaraman V, Whitney S, Tovanabutra S, Moscoso C
J Virol. 2015; 89(15):7478-93.
PMID: 25972551
PMC: 4505676.
DOI: 10.1128/JVI.00412-15.
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
Jalah R, Torres O, Mayorov A, Li F, Antoline J, Jacobson A
Bioconjug Chem. 2015; 26(6):1041-53.
PMID: 25970207
PMC: 4472500.
DOI: 10.1021/acs.bioconjchem.5b00085.
Flagellin as carrier and adjuvant in cocaine vaccine development.
Lockner J, Eubanks L, Choi J, Lively J, Schlosburg J, Collins K
Mol Pharm. 2014; 12(2):653-62.
PMID: 25531528
PMC: 4319694.
DOI: 10.1021/mp500520r.
Adjuvants for vaccines to drugs of abuse and addiction.
Alving C, Matyas G, Torres O, Jalah R, Beck Z
Vaccine. 2014; 32(42):5382-9.
PMID: 25111169
PMC: 4403865.
DOI: 10.1016/j.vaccine.2014.07.085.
Synthesis and immunological effects of heroin vaccines.
Li F, Cheng K, Antoline J, Iyer M, Matyas G, Torres O
Org Biomol Chem. 2014; 12(37):7211-32.
PMID: 24995943
PMC: 4146676.
DOI: 10.1039/c4ob01053a.
Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine.
Matyas G, Rice K, Cheng K, Li F, Antoline J, Iyer M
Vaccine. 2014; 32(13):1473-9.
PMID: 24486371
PMC: 4090106.
DOI: 10.1016/j.vaccine.2014.01.028.
